In 2023, the re-import of prepared culture media for developing micro-organisms to China was positioned at a significant volume, establishing a foundation for future growth. The forecast from 2024 to 2028 indicates a consistent increase in volume, with a year-on-year rise of approximately 6%. This trend reflects the growing demand in China's biomedical and pharmaceutical sectors. The Compound Annual Growth Rate (CAGR) over these five years is anticipated to be around 6%, underscoring steady market expansion.

Future trends to watch for:

Technological advancements in microbiological research and diagnostics, fueling increased demand.
Government policies promoting biotechnology and healthcare innovation, potentially impacting import dynamics.
Trade relations and tariff adjustments that could influence re-import volumes.